508 related articles for article (PubMed ID: 14737978)
1. [HLA-G: immunoregulatory molecule involved in allograft acceptance].
Creput C; Durrbach A; Charpentier B; Carosella ED; Rouas-Freiss N
Nephrologie; 2003; 24(8):451-6. PubMed ID: 14737978
[TBL] [Abstract][Full Text] [Related]
2. The immunotolerance role of HLA-G.
Rouas-Freiss N; Khalil-Daher I; Riteau B; Menier C; Paul P; Dausset J; Carosella ED
Semin Cancer Biol; 1999 Feb; 9(1):3-12. PubMed ID: 10092545
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways.
Le Rond S; Gonzalez A; Gonzalez AS; Carosella ED; Rouas-Freiss N
Immunology; 2005 Nov; 116(3):297-307. PubMed ID: 16236119
[TBL] [Abstract][Full Text] [Related]
4. [HLA-G in organ transplantation].
Le Maoult J; Rouas-Freiss N; Le Discorde M; Moreau P; Carosella ED
Pathol Biol (Paris); 2004 Mar; 52(2):97-103. PubMed ID: 15001239
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation.
Baştürk B; Karakayali F; Emiroğlu R; Sözer O; Haberal A; Bal D; Haberal M
Transplant Proc; 2006 Mar; 38(2):571-4. PubMed ID: 16549178
[TBL] [Abstract][Full Text] [Related]
7. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
9. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients.
Le Rond S; Le Maoult J; Créput C; Menier C; Deschamps M; Le Friec G; Amiot L; Durrbach A; Dausset J; Carosella ED; Rouas-Freiss N
Eur J Immunol; 2004 Mar; 34(3):649-660. PubMed ID: 14991594
[TBL] [Abstract][Full Text] [Related]
10. [Non-classical human leukocyte antigen (HLA) tissue types--from implantation to transplantation].
Hviid TV
Ugeskr Laeger; 2006 Jan; 168(5):461-6. PubMed ID: 16472433
[TBL] [Abstract][Full Text] [Related]
11. Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients.
Rondelli D; Abbasian J; Arpinati M; Panaro F; Porubsky M; Manzelli A; Oberholzer J; Benedetti E; Testa G
Transplant Proc; 2005; 37(1):49-50. PubMed ID: 15808543
[TBL] [Abstract][Full Text] [Related]
12. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
[TBL] [Abstract][Full Text] [Related]
13. Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients.
Zarkhin V; Talisetti A; Li L; Wozniak LJ; McDiarmid SV; Cox K; Esquivel C; Sarwal MM
Transplantation; 2010 Nov; 90(9):1000-5. PubMed ID: 20814356
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation.
Créput C; Durrbach A; Menier C; Guettier C; Samuel D; Dausset J; Charpentier B; Carosella ED; Rouas-Freiss N
J Hepatol; 2003 Oct; 39(4):587-94. PubMed ID: 12971970
[TBL] [Abstract][Full Text] [Related]
17. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
[TBL] [Abstract][Full Text] [Related]
18. Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft outcome.
Crispim JC; Mendes-Junior CT; Wastowski IJ; Costa R; Castelli EC; Saber LT; Donadi EA
Tissue Antigens; 2008 Jan; 71(1):35-41. PubMed ID: 17971051
[TBL] [Abstract][Full Text] [Related]
19. Dimerization of soluble HLA-G by IgG-Fc fragment augments ILT2-mediated inhibition of T-cell alloresponse.
Zhong M; Weng X; Liang Z; Lu S; Li J; Chen X; Li Q; Sun W; Song Y; Shen G; Wu X
Transplantation; 2009 Jan; 87(1):8-15. PubMed ID: 19136885
[TBL] [Abstract][Full Text] [Related]
20. Structure, expression and function of HLA-G in renal cell carcinoma.
Seliger B; Schlaf G
Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
